| |
| |
|
| Insider
Information: |
Klarman Seth A |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
35,066,528 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$261,188,890 |
|
|
| Total
Shares |
35,066,528 |
|
|
| Total
Value |
$261,188,890 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
4
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
3.0
|
| Percentage
Gain/Loss : |
 -15.6%
|
-22.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rhi Entertainment, Inc. |
RHIEQ |
10% Owner |
|
0 |
2009-12-24 |
0 |
Premium* |
|
|
Breitburn Energy Partners L.p. |
BBEP |
10% Owner |
|
0 |
2009-04-27 |
8,495,939 |
Premium* |
|
|
Idenix Pharmaceuticals Inc |
IDIX |
10% Owner |
|
0 |
2014-08-05 |
0 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
10% Owner |
|
0 |
2018-12-12 |
0 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
|
0 |
2018-10-31 |
0 |
Premium* |
|
|
Translate Bio, Inc. |
TBIO |
10% Owner |
|
0 |
2021-09-14 |
0 |
Premium* |
|
|
Garrett Motion Inc. |
GTX |
|
|
0 |
2023-06-15 |
26,570,589 |
Premium* |
|
|
Veritiv Corp |
VRTV |
|
|
0 |
2023-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTV |
Veritiv Corp |
|
• • • |
2023-11-30 |
4 |
D |
$170.00 |
$565,135,080 |
I/I |
(3,324,324) |
0 |
0 |
- |
|
| VRTV |
Veritiv Corp |
10% Owner |
– – • |
2023-08-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,324,324 |
|
% |
|
| GTX |
Garrett Motion Inc. |
|
• • • |
2023-06-15 |
4 |
S |
$7.55 |
$7,738,750 |
I/I |
(1,025,000) |
26,570,589 |
0 |
% |
|
| GTX |
Garrett Motion Inc. |
|
• • • |
2023-06-14 |
4 |
S |
$7.73 |
$23,963,000 |
I/I |
(3,100,000) |
27,595,589 |
0 |
% |
|
| GTX |
Garrett Motion Inc. |
|
• • • |
2023-06-13 |
4 |
S |
$8.00 |
$4,000,000 |
I/I |
(500,000) |
30,695,589 |
0 |
% |
|
| GTX |
Garrett Motion Inc. |
|
• • • |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
I/I |
25,462,810 |
31,195,589 |
0 |
- |
|
| TBIO |
Translate Bio, Inc. |
10% Owner |
– – • |
2021-09-14 |
4/A |
D |
$38.00 |
$685,681,082 |
I/I |
(18,044,239) |
0 |
0 |
- |
|
| GTX |
Garrett Motion Inc. |
10% Owner |
– – • |
2021-04-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(3,575,000) |
0 |
0 |
- |
|
| GTX |
Garrett Motion Inc. |
10% Owner |
– – • |
2020-10-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,575,000 |
|
% |
|
| TBIO |
Translate Bio, Inc. |
10% Owner |
– – • |
2020-06-26 |
4 |
B |
$22.00 |
$11,000,000 |
I/I |
500,000 |
18,044,239 |
1.5 |
% |
|
| TBIO |
Translate Bio, Inc. |
10% Owner |
– – • |
2019-09-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,544,239 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
10% Owner |
– – • |
2018-12-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(65,374,013) |
0 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
10% Owner |
– – • |
2018-12-11 |
4 |
A |
$0.00 |
$164,746,211 |
I/I |
39,582,335 |
65,374,013 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2018-10-31 |
4 |
S |
$0.01 |
$8,963 |
I/I |
(896,339) |
0 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2018-10-29 |
4 |
S |
$0.01 |
$6,500 |
I/I |
(650,000) |
896,339 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2018-10-25 |
4 |
S |
$0.01 |
$6,525 |
I/I |
(652,500) |
1,546,339 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2018-10-24 |
4 |
S |
$0.01 |
$280 |
I/I |
(28,000) |
2,198,839 |
0 |
- |
|
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2016-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
22,268,399 |
|
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
10% Owner |
– – • |
2015-10-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
42,016,276 |
|
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
10% Owner |
– – • |
2014-08-05 |
4 |
D |
$24.50 |
$1,306,612,171 |
I/I |
(53,331,109) |
0 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
10% Owner |
– – • |
2014-01-31 |
4 |
B |
$6.50 |
$106,731,567 |
I/I |
16,420,241 |
53,331,109 |
1.5 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
10% Owner |
– – • |
2013-11-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
36,910,868 |
|
- |
|
| RHIEQ |
Rhi Entertainment, Inc. |
10% Owner |
– – • |
2009-12-24 |
4/A |
S |
$0.28 |
$1,731,218 |
I/I |
(4,900,551) |
0 |
0 |
- |
|
| BBEP |
Breitburn Energy Partners... |
10% Owner |
– – • |
2009-04-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,495,939 |
|
- |
|
| RHIEQ |
Rhi Entertainment, Inc. |
10% Owner |
– – • |
2009-03-30 |
4/A |
B |
$1.19 |
$520,050 |
I/I |
437,017 |
4,900,551 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
